We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » First-In-Class Blood Pressure Treatment Clears FDA
First-In-Class Blood Pressure Treatment Clears FDA
March 9, 2007
Novartis will position its newly approved antihypertensive Tekturna as a new treatment option in a therapeutic category where nearly seven out of 10 patients do not reach their respective blood pressure targets, the company said.